Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
CCOSMOS Pharmaceutical Corporation logo
3349TSE Prime

COSMOS Pharmaceutical Corporation

コスモス薬品 Yahoo Finance

Recent & upcoming events

Aug 27
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
Jul 13
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Oct 13
Earnings 2:00 approx.
Q1 earnings announcement (scheduled)
Add to Google Calendar
Nov 25
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Nov 26
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
2027
Jan 12
Est.
Earnings 1:00 approx.
Q2 earnings
Add to Google Calendar
Apr 13
Est.
Earnings 2:00 approx.
Q3 earnings
Add to Google Calendar
May 26
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
May 27
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Jul 13
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥1.10T YoY +8.7%
Operating income ¥42.35B margin 3.9%
Net income ¥32.05B YoY +3.4%
EPS ¥404 YoY +3.4%
P/E —
ROE 11.8% Equity ratio 48% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/05 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥1.19T +8.2%
Operating income ¥43.00B +1.5%
Net income ¥30.70B -4.2%
EPS ¥387 -4.2%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY24 Q3
Revenue ¥221.40B¥241.65B¥234.78B¥238.88B¥249.68B—
Operating income ¥7.96B¥8.99B¥6.85B¥7.90B¥7.76B—
Net income ¥7.51B¥6.51B¥5.08B¥5.77B¥7.10B—
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2025）

創業家 38.7%国内機関 22.7%海外機関 3.4%その他 3.8%未開示 29.7%20212022202320242025
創業家国内機関海外機関個人その他未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

有限会社萬緑 38.7%有限会社萬緑日本マスタートラスト信託銀行株式会社 8.7%日本マスタートラスト信託銀行株式会社（信託口）株式会社日本カストディ銀行（信託口） 5.8%株式会社日本カストディ銀行（信託口）公益財団法人余慶会 3.8%公益財団法人余慶会管理信託（A036）受託者　株式会社 3%管理信託（A036）受託者　株式会社SMBC信託銀行管理信託（A037）受託者　株式会社 2.6%管理信託（A037）受託者　株式会社SMBC信託銀行管理信託（A038）受託者　株式会社 2.6%管理信託（A038）受託者　株式会社SMBC信託銀行コスモス薬品従業員持株会 1.8%コスモス薬品従業員持株会20212022202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
有限会社萬緑 30,636,000 38.7% Yuho (EDINET)
日本マスタートラスト信託銀行株式会社（信託口） 6,880,000 8.7% Yuho (EDINET)
株式会社日本カストディ銀行（信託口） 4,571,000 5.8% Yuho (EDINET)
公益財団法人余慶会 3,000,000 3.8% Yuho (EDINET)
管理信託（A036）受託者 株式会社SMBC信託銀行 2,400,000 3.0% Yuho (EDINET)
管理信託（A037）受託者 株式会社SMBC信託銀行 2,052,000 2.6% Yuho (EDINET)
管理信託（A038）受託者 株式会社SMBC信託銀行 2,051,000 2.6% Yuho (EDINET)
THE NOMURA TRUST AND BANKING CO.,LTD. AS THE TRUSTEE OF REPURCHASE AGREEMENT MOTHER FUND 1,520,000 1.9% Yuho (EDINET)
コスモス薬品従業員持株会 1,426,000 1.8% Yuho (EDINET)
STATE STREET BANK AND TRUST COMPANY 505001 1,203,000 1.5% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

5/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 5.4%
✓ Positive operating cash flow ¥58.79B
✗ ROA improved YoY 5.9% → 5.4%
✓ Operating CF exceeds net income (accrual quality) OCF ¥58.79B / net income ¥32.05B
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 49.1% → 47.6%
✓ Current ratio improved 0.75× → 0.77×
✓ No dilution (shares outstanding did not increase) 80,001,600 → 80,001,600
✗ Gross margin improved 21.1% → 20.9%
✗ Asset turnover improved 1.93× → 1.84×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 47.6%
Current ratio 0.8×
Years of positive operating CF 11 of last 11 yrs
Payout ratio 20%
Latest fiscal year result Profit (net income ¥32.05B)

Performance history

Last 10 years
0.0兆円0.3兆円0.5兆円0.8兆円1.1兆円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 5,0275,5806,1116,8447,2647,5548,2779,65010,11410,996
Operating income 222227248291331298301315404424
Ordinary income 246253273316358329331343432446
Net income 182176192214272232238245310320
Total assets 2,2572,5062,7363,2033,4133,6314,2104,7655,2485,965
Equity 9311,0891,2631,4571,7061,9052,1112,3142,5752,837

Indicators & cash flow

*Split-adjustedUnit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥460¥445¥484¥541¥686¥585¥601¥617¥391¥404
ROE 21.5%17.5%16.3%15.8%17.2%12.8%11.9%11.1%12.7%11.8%
Operating CF 369326344655279322544552525588
Investing CF -284-305-300-270-194-437-491-573-554-819
Financing CF -80.9-81.9-69.8-54.1-55.1-62.232.585.377.2193
FCF 85.321.343.438584.9-11553.2-21.5-29.8-231

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data